Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes

(NasdaqGM:AVDL), NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. DUBLIN, Jan. 12, 2026 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a public limited company incorporated in Ireland (“Avadel” […]

XPO Schedules Fourth Quarter 2025 Earnings Conference Call for Thursday, February 5, 2026

(NYSE:XPO), GREENWICH, Conn., Jan. 12, 2026 (GLOBE NEWSWIRE) — XPO (NYSE: XPO) will hold its fourth quarter conference call and webcast on Thursday, February 5, at 8:30 a.m. Eastern Time. The company's results will be released earlier that morning and made available on www.xpo.com. Access information:Call toll-free from US/Canada: 1-877-269-7756International callers: +1-201-689-7817Live webcast online at:

Zscaler Appoints Dr. Swamy Kocherlakota as Executive Vice President of Agentic AI Security Engineering

(NASDAQ:ZS), SAN JOSE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced the appointment of Dr. Swamy Kocherlakota as Executive Vice President of Agentic AI Security Engineering to address a fundamental shift: AI is evolving from chat bots into autonomous agents that function as both users

Coherent Expands WaveShaper Portfolio With the New 1000A Sharp High-Resolution Programmable Optical Filter

(NYSE:COHR), SAXONBURG, Pa., Jan. 12, 2026 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced the launch of the WaveShaper 1000A Sharp, a new programmable optical filter delivering industry-leading fine ('sharp') frequency resolution. Featuring a 5GHz resolution optical bandwidth, the WaveShaper 1000A Sharp offers approximately two times finer resolution than

LifeVantage Kicked Off 2026 With Global Kickoff, a Virtual Event Showcasing Innovation and Integration

(NASDAQ:LFVN), SALT LAKE CITY, Jan. 12, 2026 (GLOBE NEWSWIRE) — LifeVantage Corporation(R) (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, announced the successful conclusion of its Global Kickoff, a virtual company-wide event that united LifeVantage Consultants worldwide and set the tone for a new

Astera Labs Announces First Quarter 2026 Financial Conference Participation

(NASDAQ:ALAB), SAN JOSE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) — Astera Labs (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced that it will participate in the following upcoming financial conferences during the first quarter 2026: 28th Annual Needham Growth Conference on Jan. 14th in New York. Astera Labs' presentation

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

(NasdaqGM:LBRX), NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that it has granted to Ellen Rose, the new Senior Vice President, Corporate Affairs and Lindsay Beaupre, the new Senior Vice President of People and Culture of LB Pharmaceuticals, equity awards outside of, but

INTEGRA RECEIVES FEDERAL PERMITTING SCHEDULE FOR DELAMAR HEAP LEACH PROJECT; CLEAR AND ACCELERATED PATHWAY TARGETING A RECORD OF DECISION IN 2027

TSXV: ITR; NYSE American: ITRG www.integraresources.com Integra Resources Corp. (“Integra” or the “Company”) (TSXV: ITR) (NYSE American: ITRG) is pleased to announce that the United States Bureau of Land Management (“BLM”) has formally established a federal permitting schedule under the National Environmental Policy Act (“NEPA”) for the Company’s DeLamar Heap Leach Project (“DeLamar” or the

BioMarin Appoints Arpit Davé Chief Digital and Information Officer

Mr. Davé Brings more than 20 Years of Experience in Creating Enterprise Value through Digital Transformation, Information Technology and Artificial Intelligence across the Biopharmaceutical Industry BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced it has appointed Arpit Davé as Executive Vice President, Chief Digital and Information Officer, a new position reporting directly to President and Chief

AB Announces December 31, 2025 Assets Under Management

AllianceBernstein L.P. (“AB”) and AllianceBernstein Holding L.P. (“AB Holding”) (NYSE: AB) today announced that preliminary assets under management (“AUM”) increased to $867 billion during December 2025 from $865 billion at the end of November. The $2 billion month-end increase was driven by market appreciation. Total net flows were slightly negative for the month, as strong

Scroll to Top